ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,363.36
1.81%
US Tech 100
18,164.80
1.78%
다우존스 지수
40,212.71
1.56%
Bitcoin
84,927.99
1.47%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Prime Medicine Inc (PRME) 시세

Prime Medicine Inc

Prime Medicine Inc (PRME)

Prim SA
Prim SA
Prim SA
Prim SA
Prime Drink Group Corp
1.33
0.16
(13.68%)
마감 14 4월 5:00AM
15분 지연
1.33
0.00
(0.00%)
시간외 거래: 7:50AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
1.33
매수가
1.09
매도가
1.99
거래량
1,758,892
1.16 일간 변동폭 1.33
1.115 52주 범위 8.27
market_cap
174.444M
전일 종가
1.17
개장가
1.18
최근 거래 시간
100
@
1.33
(formt)
마지막 거래 시간
재정 규모
US$ 2,242,705
VWAP
1.2751
평균 볼륨(3m)
1,321,224
발행 주식
131,160,842
배당수익률
-
주가수익률
-0.88
주당순이익(EPS)
-1.49
매출
2.98M
순이익
-195.88M

Prime Medicine Inc 정보

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome a... Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs. 더 보기

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
웹사이트
www.primemedicine.com
본부
Wilmington, Delaware, USA
설립됨
-
Prime Medicine Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker PRME. The last closing price for Prime Medicine was US$1.17. Over the last year, Prime Medicine shares have traded in a share price range of US$ 1.115 to US$ 8.27.

Prime Medicine currently has 131,160,842 shares in issue. The market capitalisation of Prime Medicine is US$153.46 million. Prime Medicine has a price to earnings ratio (PE ratio) of -0.88.

PRME 최신 뉴스

추가 뉴스

Form 8-K - Current report
Edgar (US Regulatory)
18 3월 2025
PRME (13.68%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 3월 2025
PRME (13.68%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 3월 2025
PRME (13.68%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
28 2월 2025
PRME (13.68%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
28 2월 2025
PRME (13.68%)

Form 8-K - Current report
Edgar (US Regulatory)
28 2월 2025
PRME (13.68%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.2-13.07189542481.531.541.11523096861.27164875CS
4-0.42-241.752.29921.11516469361.67749868CS
12-1.57-54.13793103452.93.361.11513212242.15870863CS
26-2.24-62.74509803923.574.711.11512148262.78798582CS
52-4.66-77.7963272125.998.271.11511634803.7905214CS
156-17.64-92.988929889318.9721.73011.1157171036.29205146CS
260-17.64-92.988929889318.9721.73011.1157171036.29205146CS

PRME - Frequently Asked Questions (FAQ)

What is the current Prime Medicine share price?
The current share price of Prime Medicine is US$ 1.33
How many Prime Medicine shares are in issue?
Prime Medicine has 131,160,842 shares in issue
What is the market cap of Prime Medicine?
The market capitalisation of Prime Medicine is USD 153.46M
What is the 1 year trading range for Prime Medicine share price?
Prime Medicine has traded in the range of US$ 1.115 to US$ 8.27 during the past year
What is the PE ratio of Prime Medicine?
The price to earnings ratio of Prime Medicine is -0.88
What is the cash to sales ratio of Prime Medicine?
The cash to sales ratio of Prime Medicine is 58.15
What is the reporting currency for Prime Medicine?
Prime Medicine reports financial results in USD
What is the latest annual turnover for Prime Medicine?
The latest annual turnover of Prime Medicine is USD 2.98M
What is the latest annual profit for Prime Medicine?
The latest annual profit of Prime Medicine is USD -195.88M
What is the registered address of Prime Medicine?
The registered address for Prime Medicine is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Prime Medicine website address?
The website address for Prime Medicine is www.primemedicine.com
Which industry sector does Prime Medicine operate in?
Prime Medicine operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
MSPRMSP Recovery Inc
US$ 2.479
(93.67%)
87.38M
PRTGPortage Biotech Inc
US$ 8.5091
(66.85%)
31.29M
WTOUTime Limited
US$ 2.15
(61.65%)
1.19M
BFRGBullfrog AI Holdings Inc
US$ 2.09
(48.23%)
13.81M
THTXTheratechnologies Inc
US$ 1.94
(45.86%)
49.4M
TOROVToro Corporation
US$ 1.43
(-82.48%)
109.39k
LUCYInnovative Eyewear Inc
US$ 2.3471
(-52.58%)
1.98M
XHGXChange TED Inc
US$ 0.1985
(-45.71%)
8.7M
MULNMullen Automotive Inc
US$ 2.18
(-39.44%)
4.35M
FLDFold Holdings Inc
US$ 2.6601
(-33.50%)
1.74M
DMNDamon Inc
US$ 0.003
(-28.57%)
1.04B
BONBon Natural Life Ltd
US$ 0.066
(8.73%)
653.46M
STSSSharps Technology Inc
US$ 0.0245
(33.88%)
640.47M
NVDANVIDIA Corporation
US$ 110.93
(3.12%)
303.97M
LGMKLogicMark Inc
US$ 0.009699
(3.18%)
261.75M

PRME Discussion

게시물 보기
Monksdream Monksdream 4 월 전
PRME, under $

👍️0
PonkenPlonken PonkenPlonken 4 월 전
Super super undervalued..
Recent PSTX - Roche deal should have made this run? Atleast given it also recently partnered with BMS... makes zero sense.
Is a clear validation CRISPR genome editing is hot in cancer cell therapy.
Waiting for a sign....
👍️0
Monksdream Monksdream 6 월 전
PRME under $5
👍️0
Monksdream Monksdream 6 월 전
PRME new 52 week low
👍️0
Invest-in-America Invest-in-America 6 월 전
PRME: Glad I grabbed a chunk of THIS ONE!!!!
👍️0
PonkenPlonken PonkenPlonken 6 월 전
"Under the terms of the agreement, Prime Medicine will receive a $55 million upfront payment and a $55 million equity investment from Bristol Myers Squibb. Prime Medicine is also eligible to receive more than $3.5 billion in milestones,..."

"On the Effective Date, the Company entered into the Purchase Agreement with BMS, pursuant to which the Company agreed to issue and sell, and BMS agreed to purchase, in an unregistered offering (the “Offering”), 11,006,163 shares [...] for an aggregate purchase price of $55.0 million..."
👍️0
Monksdream Monksdream 7 월 전
PRME new 52=week low
👍️0
wiwineguy wiwineguy 7 월 전
K. I'm in!
👍️0
Monksdream Monksdream 7 월 전
DAKT
👍️0
wiwineguy wiwineguy 7 월 전
You are amazing Monk. Any recommendations
👍️0
Monksdream Monksdream 7 월 전
PRME under $5
👍️0
Monksdream Monksdream 8 월 전
PRME new 52 week low
👍️0
Monksdream Monksdream 9 월 전
PRME under $6
👍️0
Monksdream Monksdream 9 월 전
PRME under $10:
👍️0
Monksdream Monksdream 10 월 전
Great post
Friday Cathie Wood bought more shares for her flagship Ark Fund (ARKK)
I think she has been buying on the decline
She isn’t particularly interested in how well or how lousy the management controls costs it’s the potential she believes exists
There are about a dozen, if not more, listed gene editing companies
Not all will make it before they run out of money and have to raise more operating capital
Notice the $2 to $4 bounces on the way to lower lows
👍️0
Monksdream Monksdream 11 월 전
PRME under $10
👍️0
jondoeuk jondoeuk 11 월 전
PRME vs Tome vs Tessera vs NTLA vs CRSP vs...!

They fact this article needs to be written could mean a legal battle is coming https://www.nature.com/articles/s41587-024-02208-0
👍️0
NY1972 NY1972 12 월 전
This $500M company burns $200M a year. These PhDs have been spoiled by Wall St. when money was cheap. Who wants to be their sugar daddy?
👍️0
jondoeuk jondoeuk 12 월 전
I'm sure in the (near) future they will (functionally) cure (rare) diseases, but not before they dilute a whole bunch more.
👍️0
jondoeuk jondoeuk 1 년 전
The CEO has been contently telling investors how easy it would be to bring in funding through partnerships and how difficult capital markets are. Yet they did a secondary. He needs to go. Also, I don't think their IP is gatekeeping others.
👍️0

최근 히스토리

NASDAQ
PRME
Prime Medicine
AQSE
BREE.GB
Breedon
COIN
XSGDUSD
XSGD
USOTC
CDIGF
C and D International In... (PK)
NYSE
PERF.WS
Perfect
USOTC
AAFRF
Airtel Africa (PK)
USOTC
LGNYZ
Ligand Pharmaceuticals (PK)
USOTC
SHMTF
Sahamitr Pressure Contai... (CE)
BOV
KRSA3
Kora Saude Participacoes... ON
USOTC
MMSHY
McMillan Shakespeare (PK)
COIN
COOKUST
Cook Token
NASDAQ
CAIWX
Canoe Energy Portfolio C...
NASDAQ
CCJDX
Ci Canadian Investment C...
BOV
OFSA3
OUROFINO S/A ON
LSE
XNJS
X Japan Nz Pa
NASDAQ
FRGO
Fargo
Delayed Upgrade Clock
ADVFN Logo
대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지